These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19115469)

  • 1. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A; Polyak S; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
    Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ; Basseri B; Papadakis KA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    Da Cunha T; Vaziri H
    J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic features of colorectal neoplasia in inflammatory bowel diseases.
    Bressenot A; Cahn V; Danese S; Peyrin-Biroulet L
    World J Gastroenterol; 2014 Mar; 20(12):3164-72. PubMed ID: 24696602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer in inflammatory bowel disease.
    Xie J; Itzkowitz SH
    World J Gastroenterol; 2008 Jan; 14(3):378-89. PubMed ID: 18200660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
    Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Collins PD; Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.